Protection from experimental asthma by an endogenous bronchodilator.
- Authors
- Que, Loretta G; Liu, Limin; Yan, Yun; Whitehead, Gregory S; Gavett, Stephen H; Schwartz, David A; Stamler, Jonathan S
- Year
- 2005
- Journal
- Science (New York, N.Y.)
- PMID
- 15919956
- DOI
- 10.1126/science.1108228
- PMCID
- PMC2128762
Mechanisms that protect against asthma remain poorly understood. S-nitrosoglutathione (GSNO), an endogenous bronchodilator, is depleted from asthmatic airways, suggesting a protective role. We report that, following allergen challenge, wild-type mice exhibiting airway hyperresponsivity have increased airway levels of the enzyme GSNO reductase (GSNOR) and are depleted of lung S-nitrosothiols (SNOs). In contrast, mice with genetic deletion of GSNOR exhibit increases in lung SNOs and are protected from airway hyperresponsivity. Our results indicate that endogenous SNOs, governed by GSNOR, are critical regulators of airway responsivity and may provide new therapeutic approaches to asthma.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genes encoding enzymes involved in ethanol metabolism. | 2012 | 23134050 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Supersulfide biology and translational medicine for disease control. | Barayeu U et al. | β | 2026 | β |
| Fraction of Nitric Oxide in Exhaled Breath. | Barochia A et al. | β | 2025 | β |
| Mechanistic Insights into the Effects of Astaxanthin on Asthma in Mice: A Combined Transcriptomic and Metabolomic Analysis | Ma ZH et al. | β | 2025 | β |
| Pharmacologic Inhibition of S-Nitrosoglutathione Reductase Prevents Hyperoxic Alveolar and Airway Disease in Newborn Mice. | Adaikalam S et al. | β | 2025 | β |
| Severe asthma beyond bronchodilators: Emerging therapeutic approaches. | Barkat MQ et al. | β | 2025 | β |
| S-nitrosylation of pVHL regulates Ξ²<sub>2</sub> adrenergic receptor function. | Grimmett ZW et al. | β | 2025 | β |
| Endogenous inhibitory mechanisms in asthma. | Chiarella SE et al. | β | 2023 | β |
| Gaps and Future Directions in Clinical Research on Obesity-Related Asthma. | Hudler AC et al. | β | 2023 | β |
| Supersulfide catalysis for nitric oxide and aldehyde metabolism. | Kasamatsu S et al. | β | 2023 | β |
| Investigational approaches for unmet need in severe asthma. | Watchorn D et al. | β | 2022 | β |
| S-Denitrosylation: A Crosstalk between Glutathione and Redoxin Systems. | Chakraborty S et al. | β | 2022 | β |
| S-nitrosylation is required for Ξ²<sub>2</sub>AR desensitization and experimental asthma. | Fonseca FV et al. | β | 2022 | β |
| Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma. | He Q et al. | β | 2022 | β |
| The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions. | Georas SN et al. | β | 2022 | β |
| Airway Thiol-NO Adducts as Determinants of Exhaled NO. | Pophal M et al. | β | 2021 | β |
| Bronchopulmonary Dysplasia and Pulmonary Hypertension. The Role of Smooth Muscle <i>adh5</i>. | Raffay TM et al. | β | 2021 | β |
| Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease. | Sircar E et al. | β | 2021 | β |
| Nitric Oxide and S-Nitrosylation in Cardiac Regulation: G Protein-Coupled Receptor Kinase-2 and Ξ²-Arrestins as Targets. | Kayki-Mutlu G et al. | β | 2021 | β |
| Anaerobic Transcription by OxyR: A Novel Paradigm for Nitrosative Stress. | Seth D et al. | β | 2020 | β |
| An updated mode of action and human relevance framework evaluation for Formaldehyde-Related nasal tumors. | Thompson CM et al. | β | 2020 | β |
| An Update on Thiol Signaling: S-Nitrosothiols, Hydrogen Sulfide and a Putative Role for Thionitrous Acid. | Marozkina N et al. | β | 2020 | β |
| Endoplasmic reticulum stress and glutathione therapeutics in chronic lung diseases. | Janssen-Heininger Y et al. | β | 2020 | β |
| T2-"Low" Asthma: Overview and Management Strategies. | Fitzpatrick AM et al. | β | 2020 | β |
| Transnitrosylation Mediated by the Non-canonical Catalase ROG1 Regulates Nitric Oxide Signaling in Plants. | Chen L et al. | β | 2020 | β |
| Identification of a Novel Inhibitor of Human Rhinovirus Replication and Inflammation in Airway Epithelial Cells. | Yang Z et al. | β | 2019 | β |
| Improvement in Outcomes After Cardiac Arrest and Resuscitation by Inhibition of S-Nitrosoglutathione Reductase. | Hayashida K et al. | β | 2019 | β |
| Nitrite-stimulated Gastric Formation of S-nitrosothiols As An Antihypertensive Therapeutic Strategy. | Oliveira-Paula GH et al. | β | 2019 | β |
| Protein S-Nitrosylation: Determinants of Specificity and Enzymatic Regulation of S-Nitrosothiol-Based Signaling. | Stomberski CT et al. | β | 2019 | β |
| Protein S-Nitrosylation in plants: Current progresses and challenges. | Feng J et al. | β | 2019 | β |
| S-Nitrosoglutathione Mimics the Beneficial Activity of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide in a Mouse Model of Stroke. | Khan M et al. | β | 2019 | β |
| The Effect of Alcohol Dehydrogenase Isozymes on Alcoholic Liver Disease and Alcoholic Osteoporosis. | Okuda T | β | 2019 | β |
| Tracheomalacia in bronchopulmonary dysplasia: Trachealis hyper-relaxant responses to S-nitrosoglutathione in a hyperoxic murine model. | Einisman HJ et al. | β | 2019 | β |
| Amelioration of spinal cord injury in rats by blocking peroxynitrite/calpain activity. | Khan M et al. | β | 2018 | β |
| Effect of the S-nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma. | Que LG et al. | β | 2018 | β |
| Exercise-Induced Bronchoconstriction and the Air We Breathe. | Rundell KW et al. | β | 2018 | β |
| GSNO promotes functional recovery in experimental TBI by stabilizing HIF-1Ξ±. | Khan M et al. | β | 2018 | β |
| Nitric Oxide Signaling in T Cell-Mediated Immunity. | GarcΓa-Ortiz A et al. | β | 2018 | β |
| Pathophysiological Role of S-Nitrosylation and Transnitrosylation Depending on S-Nitrosoglutathione Levels Regulated by S-Nitrosoglutathione Reductase. | Choi MS | β | 2018 | β |
| Pyrrole: An insight into recent pharmacological advances with structure activity relationship. | Ahmad S et al. | β | 2018 | β |
| Chronicles of a reductase: Biochemistry, genetics and physio-pathological role of GSNOR. | Rizza S et al. | β | 2017 | β |
| Non-asthmatic eosinophilic bronchitis and its relationship with asthma. | Lai K et al. | β | 2017 | β |
| Regulation of protein function by S-nitrosation and S-glutathionylation: processes and targets in cardiovascular pathophysiology. | Belcastro E et al. | β | 2017 | β |
| The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy. | Barnett SD et al. | β | 2017 | β |
| Augmentation of CFTR maturation by S-nitrosoglutathione reductase. | Zaman K et al. | β | 2016 | β |
| Daily life negative mood and exhaled nitric oxide in asthma. | Ritz T et al. | β | 2016 | β |
| Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action. | Jiang H et al. | β | 2016 | β |
| S-Nitrosoglutathione Attenuates Airway Hyperresponsiveness in Murine Bronchopulmonary Dysplasia. | Raffay TM et al. | β | 2016 | β |
| Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma. | Ghosh A et al. | β | 2016 | β |
| Targeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI. | Khan M et al. | β | 2016 | β |
| Alcohol dehydrogenase 3 contributes to the protection of liver from nonalcoholic steatohepatitis. | Goto M et al. | β | 2015 | β |
| Blocking a vicious cycle nNOS/peroxynitrite/AMPK by S-nitrosoglutathione: implication for stroke therapy. | Khan M et al. | β | 2015 | β |
| Contribution of Fdh3 and Glr1 to Glutathione Redox State, Stress Adaptation and Virulence in Candida albicans. | Tillmann AT et al. | β | 2015 | β |
| Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection. | Chung HS et al. | β | 2015 | β |
| Glutathione metabolism links FOXRED1 to NADH:ubiquinone oxidoreductase (complex I) deficiency: A hypothesis. | Lemire BD | β | 2015 | β |
| New blood: Creative funding of disease-specific research. | Seaman WE et al. | β | 2015 | β |
| Nitrogen chemistry and lung physiology. | Marozkina NV et al. | β | 2015 | β |
| Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis. | Luzina IG et al. | β | 2015 | β |
| Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity. | Marozkina NV et al. | β | 2015 | β |
| Site-specific nitrosoproteomic identification of endogenously S-nitrosylated proteins in Arabidopsis. | Hu J et al. | β | 2015 | β |
| Activation of GSNOR transcription by NF-ΞΊB negatively regulates NGF-induced PC12 differentiation. | Wu K et al. | β | 2014 | β |
| Acute glutathione depletion leads to enhancement of airway reactivity and inflammation via p38MAPK-iNOS pathway in allergic mice. | Nadeem A et al. | β | 2014 | β |
| Characterization of reactive nitrogen species in allergic asthma. | Zuo L et al. | β | 2014 | β |
| Hydrogen sulfide as a potential biomarker of asthma. | Chung KF | β | 2014 | β |
| Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation. | Blonder JP et al. | β | 2014 | β |
| Proteomic approaches to evaluate protein S-nitrosylation in disease. | LΓ³pez-SΓ‘nchez LM et al. | β | 2014 | β |
| Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters. | Anwer MS et al. | β | 2014 | β |
| Anti-inflammatory effect of arginase inhibitor and corticosteroid on airway allergic reactions in a Dermatophogoides farinae-induced NC/Nga mouse model. | Ogino K et al. | β | 2013 | β |
| Exhaled breath condensate formate after inhaled allergen provocation in atopic asthmatics in vivo. | Greenwald R et al. | β | 2013 | β |
| Increased susceptibility to Klebsiella pneumonia and mortality in GSNOR-deficient mice. | Tang CH et al. | β | 2013 | β |
| Mass spectrometry-based identification of S-nitrosocysteine in vivo using organic mercury assisted enrichment. | Doulias PT et al. | β | 2013 | β |
| Nitrosothiols in the immune system: signaling and protection. | Hernansanz-AgustΓn P et al. | β | 2013 | β |
| Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo. | Chen Q et al. | β | 2013 | β |
| Repletion of S-nitrosohemoglobin improves organ function and physiological status in swine after brain death. | Yurcisin BM et al. | β | 2013 | β |
| Routes for formation of S-nitrosothiols in blood. | Nagababu E et al. | β | 2013 | β |
| S-nitrosoglutathione. | Broniowska KA et al. | β | 2013 | β |
| S-nitrosoglutathione induces ciliary neurotrophic factor expression in astrocytes, which has implications to protect the central nervous system under pathological conditions. | Paintlia MK et al. | β | 2013 | β |
| S-nitrosoglutathione reductase inhibition regulates allergen-induced lung inflammation and airway hyperreactivity. | Ferrini ME et al. | β | 2013 | β |
| S-nitrosylation: integrator of cardiovascular performance and oxygen delivery. | Haldar SM et al. | β | 2013 | β |
| S-sulfhydration/desulfhydration and S-nitrosylation/denitrosylation: a common paradigm for gasotransmitter signaling by H2S and NO. | Lu C et al. | β | 2013 | β |
| Thioredoxin and thioredoxin reductase in relation to reversible S-nitrosylation. | Sengupta R et al. | β | 2013 | β |
| Ventilatory responses during and following exposure to a hypoxic challenge in conscious mice deficient or null in S-nitrosoglutathione reductase. | Palmer LA et al. | β | 2013 | β |
| ADH IB expression, but not ADH III, is decreased in human lung cancer. | Mutka SC et al. | β | 2012 | β |
| A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma. | Colagiovanni DB et al. | β | 2012 | β |
| Biomarkers in asthma: a real hope to better manage asthma. | Erzurum SC et al. | β | 2012 | β |
| Can nitric oxide-based therapy prevent bronchopulmonary dysplasia? | Raffay TM et al. | β | 2012 | β |
| Cardiovascular redox and ox stress proteomics. | Kumar V et al. | β | 2012 | β |
| Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function. | Beigi F et al. | β | 2012 | β |
| Effect of air pollution on athlete health and performance. | Rundell KW | β | 2012 | β |
| Effect of exposure to volatile organic compounds (VOCs) on airway inflammatory response in mice. | Wang F et al. | β | 2012 | β |
| Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease. | Anand P et al. | β | 2012 | β |
| Established Principles and Emerging Concepts on the Interplay between Mitochondrial Physiology and S-(De)nitrosylation: Implications in Cancer and Neurodegeneration. | Di Giacomo G et al. | β | 2012 | β |
| Genes encoding enzymes involved in ethanol metabolism. | Hurley TD et al. | β | 2012 | β |
| Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities. | Fitzpatrick AM et al. | β | 2012 | β |
| Increased Nitric Oxide Production Prevents Airway Hyperresponsiveness in Caveolin-1 Deficient Mice Following Endotoxin Exposure. | Hsia BJ et al. | β | 2012 | β |
| Increased stability of S-nitrosothiol solutions via pH modulations. | HornyΓ‘k I et al. | β | 2012 | β |
| Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase. | Green LS et al. | β | 2012 | β |
| Modulation of Asthma Pathogenesis by Nitric Oxide Pathways and Therapeutic Opportunities. | Ghosh S et al. | β | 2012 | β |
| Nitric oxide reduces NADPH oxidase 5 (Nox5) activity by reversible S-nitrosylation. | Qian J et al. | β | 2012 | β |
| Proteomic characterization of the cellular response to nitrosative stress mediated by s-nitrosoglutathione reductase inhibition. | Foster MW et al. | β | 2012 | β |
| Proteomics insights into deregulated protein S-nitrosylation and disease. | LΓ³pez-SΓ‘nchez LM et al. | β | 2012 | β |
| Regulation of DNA repair by S-nitrosylation. | Tang CH et al. | β | 2012 | β |
| Small things make a big difference: particulate matter and exercise. | Cutrufello PT et al. | β | 2012 | β |
| Smoke decreases reversible oxidations S-glutathionylation and S-nitrosylation in mice. | Kuipers I et al. | β | 2012 | β |
| S-nitrosoglutathione reductase in human lung cancer. | Marozkina NV et al. | β | 2012 | β |
| Spinal cord injury induced arrest in estrous cycle of rats is ameliorated by S-nitrosoglutathione: novel therapeutic agent to treat amenorrhea. | Shunmugavel A et al. | β | 2012 | β |
| Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion. | Sakakima H et al. | β | 2012 | β |
| Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification. | Sun X et al. | β | 2012 | β |
| The Γ-state dissociation continuum of NO-Ar and its near infrared spectrum. | Meyer H | β | 2012 | β |
| The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke. | Khan M et al. | β | 2012 | β |
| The role of thioredoxin in the regulation of cellular processes by S-nitrosylation. | Sengupta R et al. | β | 2012 | β |
| Thioredoxin-1 regulates cellular heme insertion by controlling S-nitrosation of glyceraldehyde-3-phosphate dehydrogenase. | Chakravarti R et al. | β | 2012 | β |
| Application of nitric oxide in drug discovery and development. | Bryan NS | β | 2011 | β |
| Biochemical effects of ozone on asthma during postnatal development. | Auten RL et al. | β | 2011 | β |
| Considerations for the implausibility of leukemia induction by formaldehyde. | Thompson CM et al. | β | 2011 | β |
| Determinants of exhaled breath condensate pH in a large population with asthma. | Liu L et al. | β | 2011 | β |
| Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities. | Sun X et al. | β | 2011 | β |
| Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases. | Sun X et al. | β | 2011 | β |
| Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins. | Savidge TC et al. | β | 2011 | β |
| Increased S-nitrosothiol levels in nonasthmatic eosinophilic bronchitis compared with cough variant asthma. | Lee BJ et al. | β | 2011 | β |
| Induction of GSNO reductase but not NOS in the lungs of mice exposed to glucan-spiked dust. | Cao Y et al. | β | 2011 | β |
| Mammalian alcohol dehydrogenases--a comparative investigation at gene and protein levels. | HΓΆΓΆg JO et al. | β | 2011 | β |
| Membrane transfer of S-nitrosothiols. | Matsumoto A et al. | β | 2011 | β |
| Modulation of NF-ΞΊB and hypoxia-inducible factor--1 by S-nitrosoglutathione does not alter allergic airway inflammation in mice. | Olson N et al. | β | 2011 | β |
| Nitrative stress in inflammatory lung diseases. | Sugiura H et al. | β | 2011 | β |
| Nitric oxide mediates relative airway hyporesponsiveness to lipopolysaccharide in surfactant protein A-deficient mice. | Pastva AM et al. | β | 2011 | β |
| Nitric oxide metabolism controlled by formaldehyde dehydrogenase (fdh, homolog of mammalian GSNOR) plays a crucial role in visual pattern memory in Drosophila. | Hou Q et al. | β | 2011 | β |
| Nitric oxide metabolism in asthma pathophysiology. | Ghosh S et al. | β | 2011 | β |
| Nitric oxide transport in blood: a third gas in the respiratory cycle. | Doctor A et al. | β | 2011 | β |
| Preclinical 28-day inhalation toxicity assessment of s-nitrosoglutathione in beagle dogs and Wistar rats. | Colagiovanni DB et al. | β | 2011 | β |
| S-nitrosoglutathione supplementation to ovalbumin-sensitized and -challenged mice ameliorates methacholine-induced bronchoconstriction. | Foster MW et al. | β | 2011 | β |
| S-nitrosothiol signals in the enteric nervous system: lessons learnt from big brother. | Savidge TC | β | 2011 | β |
| Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement. | Sun X et al. | β | 2011 | β |
| Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3. | Staab CA et al. | β | 2011 | β |
| Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine. | Wei W et al. | β | 2011 | β |
| The biochemistry of asthma. | Gaston B | β | 2011 | β |
| The effect of S-nitrosoglutathione and L-cysteine on chloride efflux from cystic fibrosis airway epithelial cells. | Servetnyk Z et al. | β | 2011 | β |
| Bacterial nitric oxide detoxification prevents host cell S-nitrosothiol formation: a novel mechanism of bacterial pathogenesis. | Laver JR et al. | β | 2010 | β |
| Breath formate is a marker of airway S-nitrosothiol depletion in severe asthma. | Greenwald R et al. | β | 2010 | β |
| Concomitant administration of nitric oxide and glucocorticoids improves protection against bronchoconstriction in a murine model of asthma. | Jonasson S et al. | β | 2010 | β |
| Direct inhibition of arginase attenuated airway allergic reactions and inflammation in a Dermatophagoides farinae-induced NC/Nga mouse model. | Takahashi N et al. | β | 2010 | β |
| Formaldehyde dehydrogenase: beyond phase I metabolism. | Thompson CM et al. | β | 2010 | β |
| Gender differences in S-nitrosoglutathione reductase activity in the lung. | Brown-Steinke K et al. | β | 2010 | β |
| GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. | Choudhry S et al. | β | 2010 | β |
| Increased nitrosoglutathione reductase activity in hypoxic pulmonary hypertension in mice. | Wu X et al. | β | 2010 | β |
| Lymphocyte development requires S-nitrosoglutathione reductase. | Yang Z et al. | β | 2010 | β |
| Mathematical philology: entropy information in refining classical texts' reconstruction, and early philologists' anticipation of information theory. | Cisne JL et al. | β | 2010 | β |
| Redox control of asthma: molecular mechanisms and therapeutic opportunities. | Comhair SA et al. | β | 2010 | β |
| Redox regulatory mechanism of transnitrosylation by thioredoxin. | Wu C et al. | β | 2010 | β |
| [Regulation of seven-transmembrane receptor (GPCR) by nitric oxide]. | Ozawa K | β | 2010 | β |
| S-Nitrosothiol biology and therapeutic potential in metabolic disease. | Kevil CG et al. | β | 2010 | β |
| S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. | Wei W et al. | β | 2010 | β |
| Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. | Dweik RA et al. | β | 2010 | β |
| Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. | Khan M et al. | β | 2009 | β |
| Commentary: mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma. | Thompson CM et al. | β | 2009 | β |
| eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. | Balligand JL et al. | β | 2009 | β |
| Genetic variants of GSNOR and ADRB2 influence response to albuterol in African-American children with severe asthma. | Moore PE et al. | β | 2009 | β |
| Kinetic and cellular characterization of novel inhibitors of S-nitrosoglutathione reductase. | Sanghani PC et al. | β | 2009 | β |
| Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma. | Fitzpatrick AM et al. | β | 2009 | β |
| Maternal exposure to particulate matter increases postnatal ozone-induced airway hyperreactivity in juvenile mice. | Auten RL et al. | β | 2009 | β |
| Medium-chain fatty acids and glutathione derivatives as inhibitors of S-nitrosoglutathione reduction mediated by alcohol dehydrogenase 3. | Staab CA et al. | β | 2009 | β |
| Nitric oxide-mediated dispersal in single- and multi-species biofilms of clinically and industrially relevant microorganisms. | Barraud N et al. | β | 2009 | β |
| Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. | Janssen-Heininger YM et al. | β | 2009 | β |
| Protection from lipopolysaccharide-induced lung injury by augmentation of airway S-nitrosothiols. | Marshall HE et al. | β | 2009 | β |
| Protein denitrosylation: enzymatic mechanisms and cellular functions. | Benhar M et al. | β | 2009 | β |
| Protein S-nitrosylation in health and disease: a current perspective. | Foster MW et al. | β | 2009 | β |
| S-nitrosoglutathione reductase: an important regulator in human asthma. | Que LG et al. | β | 2009 | β |
| S-Nitrosothiol deficiency in asthma. | Lewis SJ et al. | β | 2009 | β |
| Specific mediator inhibition by the NO donors SNP and NCX 2057 in the peripheral lung: implications for allergen-induced bronchoconstriction. | Larsson AK et al. | β | 2009 | β |
| The Janus face of alcohol dehydrogenase 3. | Staab CA et al. | β | 2009 | β |
| The ontogeny, distribution, and regulation of alcohol dehydrogenase 3: implications for pulmonary physiology. | Thompson CM et al. | β | 2009 | β |
| Vascular signaling through G protein-coupled receptors: new concepts. | Ushio-Fukai M | β | 2009 | β |
| Decreased lung function after inhalation of ultrafine and fine particulate matter during exercise is related to decreased total nitrate in exhaled breath condensate. | Rundell KW et al. | β | 2008 | β |
| Depletion of the ATPase NSF from Golgi membranes with hypo-S-nitrosylation of vasorelevant proteins in endothelial cells exposed to monocrotaline pyrrole. | Mukhopadhyay S et al. | β | 2008 | β |
| Determinants of exhaled nitric oxide levels in healthy, nonsmoking African American adults. | Levesque MC et al. | β | 2008 | β |
| Human carbonyl reductase 1 is an S-nitrosoglutathione reductase. | Bateman RL et al. | β | 2008 | β |
| Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. | Ckless K et al. | β | 2008 | β |
| Lung lining fluid glutathione attenuates IL-13-induced asthma. | Lowry MH et al. | β | 2008 | β |
| Measurement of protein S-nitrosylation during cell signaling. | Mannick JB et al. | β | 2008 | β |
| Mechanistic and dose considerations for supporting adverse pulmonary physiology in response to formaldehyde. | Thompson CM et al. | β | 2008 | β |
| Mechanistic considerations for formaldehyde-induced bronchoconstriction involving S-nitrosoglutathione reductase. | Thompson CM et al. | β | 2008 | β |
| Nitric oxide and cardiobiology-methods for intact hearts and isolated myocytes. | Hare JM et al. | β | 2008 | β |
| Novel anti-inflammatory treatments for asthma. | Bhowmick B et al. | β | 2008 | β |
| Reactive nitrogen species in refractory asthma: markers or players? | Kaminsky DA et al. | β | 2008 | β |
| Redox-based regulation of signal transduction: principles, pitfalls, and promises. | Janssen-Heininger YM et al. | β | 2008 | β |
| Reduction of S-nitrosoglutathione by alcohol dehydrogenase 3 is facilitated by substrate alcohols via direct cofactor recycling and leads to GSH-controlled formation of glutathione transferase inhibitors. | Staab CA et al. | β | 2008 | β |
| S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. | Ozawa K et al. | β | 2008 | β |
| Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels. | Batra J et al. | β | 2007 | β |
| CAT-2 amplifies the agonist-evoked force of airway smooth muscle by enhancing spermine-mediated phosphatidylinositol-(4)-phosphate-5-kinase-gamma activity. | Chen H et al. | β | 2007 | β |
| Distribution, adaptation and physiological meaning of thiols from vertebrate hemoglobins. | Reischl E et al. | β | 2007 | β |
| Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. | Savidge TC et al. | β | 2007 | β |
| Genetic variation in S-nitrosoglutathione reductase (GSNOR) and childhood asthma. | Wu H et al. | β | 2007 | β |
| Glutathione traps formaldehyde by formation of a bicyclo[4.4.1]undecane adduct. | Bateman R et al. | β | 2007 | β |
| Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. | Auten RL et al. | β | 2007 | β |
| Maintaining nitric oxide-induced airway relaxation with superoxide dismutase. | Krenn CG et al. | β | 2007 | β |
| Male sex hormones promote vagally mediated reflex airway responsiveness to cholinergic stimulation. | Card JW et al. | β | 2007 | β |
| Mitochondrial nitric oxide in the signaling of cell integrated responses. | Carreras MC et al. | β | 2007 | β |
| Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. | Whalen EJ et al. | β | 2007 | β |
| Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. | Singh D et al. | β | 2007 | β |
| Smoking is associated with an age-related decline in exhaled nitric oxide. | Sundy JS et al. | β | 2007 | β |
| Starring roles for astroglia in barrier pathologies of gut and brain. | Savidge TC et al. | β | 2007 | β |
| The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes. | Swindle EJ et al. | β | 2007 | β |
| Three paradigms of airway smooth muscle hyperresponsiveness in young guinea pigs. | Chitano P et al. | β | 2007 | β |
| Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. | Takemoto K et al. | β | 2007 | β |
| Airway acidification: interactions with nitrogen oxides and airway inflammation. | Hunt J | β | 2006 | β |
| Buffering airway acid decreases exhaled nitric oxide in asthma. | Gaston B et al. | β | 2006 | β |
| Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis. | Grasemann H et al. | β | 2006 | β |
| Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. | Prado CM et al. | β | 2006 | β |
| Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells. | Zaman K et al. | β | 2006 | β |
| Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung. | Bhandari V et al. | β | 2006 | β |
| Exercise-induced bronchoconstriction alters airway nitric oxide exchange in a pattern distinct from spirometry. | Shin HW et al. | β | 2006 | β |
| Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis. | Grasemann H et al. | β | 2006 | β |
| Leukocyte-derived IL-10 reduces subepithelial fibrosis associated with chronically inhaled endotoxin. | Garantziotis S et al. | β | 2006 | β |
| Lipopolysaccharide exposure makes allergic airway inflammation and hyper-responsiveness less responsive to dexamethasone and inhibition of iNOS. | KomlΓ³si ZI et al. | β | 2006 | β |
| Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. | Szema AM et al. | β | 2006 | β |
| Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease. | Redington AE | β | 2006 | β |
| Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. | Bove PF et al. | β | 2006 | β |
| Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. | Ten Broeke R et al. | β | 2006 | β |
| Reflex regulation of airway smooth muscle tone. | Canning BJ | β | 2006 | β |
| Requirement of transmembrane transport for S-nitrosocysteine-dependent modification of intracellular thiols. | Broniowska KA et al. | β | 2006 | β |
| S-nitrosothiol depletion in amyotrophic lateral sclerosis. | Schonhoff CM et al. | β | 2006 | β |
| S-nitrosothiol signaling in respiratory biology. | Gaston B et al. | β | 2006 | β |
| S-nitrosothiols regulate cell-surface pH buffering by airway epithelial cells during the human immune response to rhinovirus. | Carraro S et al. | β | 2006 | β |
| S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells. | Zaman K et al. | β | 2006 | β |
| Soluble guanylyl cyclase expression is reduced in allergic asthma. | Papapetropoulos A et al. | β | 2006 | β |
| Specific detection of gaseous NO and 15NO in the headspace from liquid-phase reactions involving NO-generating organic, inorganic, and biochemical samples using a mid-infrared laser. | Yi J et al. | β | 2006 | β |
| Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. | Rodrigo GJ et al. | β | 2005 | β |
| SNOR and wheeze: the asthma enzyme? | Henderson EM et al. | β | 2005 | β |